Literature DB >> 596320

One-dose and multiple-dose kinetics of minocycline in patients with renal disease.

I Sklenar, P Spring, L Dettli.   

Abstract

Kinetic analysis of minocycline concentrations in plasma and urine resulted in the following findings: In normal subjects the biological half-life is about 17 hours after the first dose and 21 hours after repeated administration. The renal drug clearance is only about 8% of the overall plasma clearance which is independent of renal function with a mean value of 47 ml/min. The fraction of the absorbed dose eliminated unchanged in the urine is only 9--19%. As a consequence the elimination rate of the drug is practically independent of renal function and decreases only 9--19% in anuric patients. The renal drug clearance depends linearly on renal function. The gastro-intestinal bio-availability of minocycline from the coated tablet preparation is incomplete. The cumulative behaviour of the drug corresponds to the kinetic parameters determined after repeated administration. It is suggested that the usual dosage regimen should be used in patients with renal disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 596320     DOI: 10.1007/bf01969570

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  13 in total

1.  Calculation of drug dosage regimens in patients with renal disease: a new nomographic method.

Authors:  P Spring
Journal:  Int J Clin Pharmacol Biopharm       Date:  1975-01

2.  Studies on the absorption and excretion of minocycline and a comparison with doxycycline.

Authors:  K Alestig; J Lindberg
Journal:  Infection       Date:  1974       Impact factor: 3.553

3.  Minocycline excretion and distribution in relation to renal function in man.

Authors:  S Carney; R A Butcher; J K Dawborn; G Pattison
Journal:  Clin Exp Pharmacol Physiol       Date:  1974 Jul-Aug       Impact factor: 2.557

4.  Pharmacokinetic studies on minocycline in man.

Authors:  H Macdonald; R G Kelly; E S Allen; J F Noble; L A Kanegis
Journal:  Clin Pharmacol Ther       Date:  1973 Sep-Oct       Impact factor: 6.875

5.  Minocycline toxicity in renal failure.

Authors:  C R George; M D Guinness; D J Lark; R A Evans
Journal:  Med J Aust       Date:  1973-03-31       Impact factor: 7.738

6.  [Excretion of doxycycline and the effect of hemodialysis in anurid].

Authors:  M Mannhart; L Dettli; P Spring
Journal:  Schweiz Med Wochenschr       Date:  1971-01-30

7.  Clinical pharmacologic studies with minocycline.

Authors:  B Bernard; E J Yin; H J Simon
Journal:  J Clin Pharmacol New Drugs       Date:  1971 Sep-Oct

8.  Influence of repetitive dosing of tetracyclines on biologic half-life in serum.

Authors:  J T Doluisio; L W Dittert
Journal:  Clin Pharmacol Ther       Date:  1969 Sep-Oct       Impact factor: 6.875

9.  Distribution and excretion of doxycycline in man.

Authors:  J Fabre; J S Pitton; J P Kunz
Journal:  Chemotherapy       Date:  1966       Impact factor: 2.544

Review 10.  Drug dosage in renal disease.

Authors:  L Dettli
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

View more
  6 in total

Review 1.  Clinical pharmacokinetics of doxycycline and minocycline.

Authors:  S Saivin; G Houin
Journal:  Clin Pharmacokinet       Date:  1988-12       Impact factor: 6.447

2.  Minocycline-induced interstitial nephritis.

Authors:  G W Hill; M Roach
Journal:  Br Med J       Date:  1979-03-24

Review 3.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

4.  Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents.

Authors:  J Fabre; H M Fox; P Dayer; L Balant
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

Review 5.  Minocycline for the Treatment of Multidrug and Extensively Drug-Resistant A. baumannii: A Review.

Authors:  Jennifer N Lashinsky; Oryan Henig; Jason M Pogue; Keith S Kaye
Journal:  Infect Dis Ther       Date:  2017-03-29

6.  Minocycline Susceptibility and tetB Gene in Carbapenem-Resistant Acinetobacter baumannii in Taiwan.

Authors:  Jia-Ling Yang; Chia-Jui Yang; Yu-Chung Chuang; Wang-Huei Sheng; Yee-Chun Chen; Shan-Chwen Chang
Journal:  Infect Drug Resist       Date:  2022-05-02       Impact factor: 4.177

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.